In the past 2 years, Weigao has adhered to the principle of "pioneering, innovating, seeking truth from facts and consolidating", driven by scientific and technological innovation and backed by scientific management, which has promoted the sustained, rapid and healthy development of the enterprise. The company developed disposable infusion consumables, surgical sutures, implantable medical catheters, cardiac stents, indwelling needles and various special-shaped needles, blood purification series products, orthopedic series products, mechatronic medical devices, therapeutic injections, biological diagnostic reagents, artificial plasma and other medical device products and medicines in China, and established a large-scale medical product industrial park, orthopedic material industrial park, medical science and technology industrial park and aerospace electronic product production base, which has now become the largest disposable medical treatment in China.
weigao group adheres to the development strategy of "people-oriented, science and technology first", and improves the scientific management mode and management system. The company takes the lead in introducing and using advanced management software such as ERP and KPI in the same industry, and its products have passed CE, ISO91, ISO13485, 3C and other certifications, and some products have passed the listing license of the US FDA. The company's testing center has been approved by the National Laboratory Accreditation Committee. The persistent pursuit of science and technology has given Weigao Group a space for survival and development. The company has been identified by the Ministry of Science and Technology and other ministries as "Key High-tech Enterprise of the National Torch Program", "Industrialization Base of the Achievements of the National High-tech Research and Development (863) Program" and "National Enterprise Technology Center", and has established enterprise postdoctoral workstations. The company actively cooperates with Changchun Institute of Applied Chemistry of Chinese Academy of Sciences, Dalian Institute of Chemical Physics of Chinese Academy of Sciences, Shenyang Institute of Metals of Chinese Academy of Sciences, Third Military Medical University, 31 Hospital, Harbin Institute of Technology (Weihai) and other scientific research institutes and institutions, and employs 1 academicians of the two academies as consultants. Relying on their talents and scientific research strength, the company has established nine R&D centers of Weigao Group in different places, based on the commanding heights of the industry, digesting and absorbing international cutting-edge technologies and developing them. More than 6 products of the company have reached the advanced level at home and abroad, and many products have filled the domestic gaps. Twenty products have been selected for various national projects such as the National 863 Plan, the National Key Torch Plan, the National High-tech Industry Demonstration Project, and the national key new products, among which the drug-coated stent system, prefilled syringes, orthopedic implant materials and other products have broken the monopoly of foreign companies on the China market.
weigao group persistently implements the famous brand strategy and cultivates famous brands. Jierui trademark was recognized as a well-known trademark in China, Jierui brand disposable sterile infusion medical device was awarded the title of China famous brand product, and Jierui brand was evaluated as the first brand of medical devices in China by China Brand Research Institute. The company has established more than 1 sales offices in more than 3 provinces, municipalities and autonomous regions, and established long-term and stable relations with more than 7, hospitals, more than 4 blood stations and more than 1,8 commercial companies. Our products not only sell well in more than 3 provinces, municipalities and autonomous regions in China, but also are directly exported to more than 5 countries and regions such as the United States, the European Union, Russia, South Africa and Brazil.
weigao group will consistently adhere to Scientific Outlook on Development, with the aim of "creating a healthy future with white messengers", take disposable medical devices and drugs as the leading factor, vigorously promote the adjustment of industrial structure, product structure and institutional structure, realize the internationalization of capital, technology and management, and strive to become a world-competitive, leading and most respected medical device and pharmaceutical enterprise in Asia, and make new efforts to promote the development of medical services in China and improve people's health.
weigao group